NasdaqCM:JYNT - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	81	9	9	11	1
12/31/2025	101	7	12	11	4
12/31/2024	114	2	9	8	5
3/31/2024	119	-11	7	11	N/A
12/31/2023	118	-10	10	15	N/A
9/30/2023	115	2	11	16	N/A
6/30/2023	112	4	11	17	N/A
3/31/2023	107	3	8	14	N/A
12/31/2022	101	1	2	8	N/A
9/30/2022	95	0	0	4	N/A
6/30/2022	89	2	-2	3	N/A
3/31/2022	85	5	6	12	N/A
12/31/2021	80	8	7	14	N/A
9/30/2021	76	18	8	17	N/A
6/30/2021	70	17	10	17	N/A
3/31/2021	63	15	7	12	N/A
12/31/2020	59	13	7	11	N/A
9/30/2020	56	4	6	10	N/A
6/30/2020	53	3	4	8	N/A
3/31/2020	51	3	4	9	N/A
12/31/2019	48	3	3	8	N/A
9/30/2019	45	2	5	8	N/A
6/30/2019	41	2	4	8	N/A
3/31/2019	39	1	4	6	N/A
12/31/2018	37	0	4	5	N/A
9/30/2018	34	-1	2	3	N/A
6/30/2018	31	-1	1	1	N/A
3/31/2018	28	-2	1	1	N/A
12/31/2017	25	-3	N/A	0	N/A
9/30/2017	24	-9	N/A	-2	N/A
6/30/2017	23	-11	N/A	-4	N/A
3/31/2017	22	-13	N/A	-6	N/A
12/31/2016	21	-15	N/A	-11	N/A
9/30/2016	19	-13	N/A	-13	N/A
6/30/2016	17	-12	N/A	-12	N/A
3/31/2016	16	-10	N/A	-11	N/A
12/31/2015	14	-9	N/A	-7	N/A
9/30/2015	12	-8	N/A	-4	N/A
6/30/2015	10	-7	N/A	-3	N/A
3/31/2015	8	-5	N/A	-2	N/A
12/31/2014	7	-3	N/A	0	N/A
9/30/2014	7	0	N/A	0	N/A
6/30/2014	6	0	N/A	0	N/A
3/31/2014	6	0	N/A	0	N/A
12/31/2013	6	0	N/A	0	N/A

애널리스트 미래 성장 예측

수입 대 저축률: JYNT 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 2.4% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: JYNT (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: JYNT 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: JYNT 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -11.7% ).

고성장 수익: JYNT 의 수익은 향후 3년 동안 감소할 것으로 예상됩니다(연간 -11.7% ).

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: JYNT 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

Joint 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Price target increased by 9.7% to US$13.38

The Joint Corp. Reiterates Sales Guidance for the Year 2024

The Joint Corp. Provides Sales Guidance for the Year 2024

Consensus EPS estimates fall by 42%

The Joint Corp. Reiterates Revenue Guidance for the Year 2023

The Joint Corp. Revises Earnings Guidance for the Year 2023

Recent updates

New minor risk - Shareholder dilution

Price target increased by 9.7% to US$13.38

Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking

First quarter 2024 earnings: EPS exceeds analyst expectations

The Joint Corp. Reiterates Sales Guidance for the Year 2024

The Joint Corp., Annual General Meeting, May 22, 2024

The Joint Corp. to Report Q1, 2024 Results on May 02, 2024

The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up

New minor risk - Share price stability

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Joint Corp. Provides Sales Guidance for the Year 2024

Investor sentiment improves as stock rises 15%

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

The Joint Corp. to Report Second Half, 2023 Results on Mar 07, 2024

Consensus EPS estimates fall by 42%

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Insufficient new directors

The Joint Corp. Reiterates Revenue Guidance for the Year 2023

The Joint Corp. Appoints Jeff Gramm to the Board of Directors, Effective January 2, 2024

The Joint Corp. to Report Q3, 2023 Results on Nov 09, 2023

The Joint Corp. Revises Earnings Guidance for the Year 2023

The Joint Announces Receipt of Delinquency Notification Letter from Nasdaq

The Joint Corp. announced delayed 10-Q filing

The Joint Corp. Appoints Lori Abou Habib as New Chief Marketing Officer

Price target decreased by 8.5% to US$27.17

The Joint Corp. to Report Q2, 2023 Results on Aug 10, 2023

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

The Joint Corp. Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target increased by 11% to US$29.70

Consensus EPS estimates fall by 44%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

The Joint Corp. to Report Q4, 2022 Results on Mar 09, 2023

The Joint Corp. Appoints Krischelle Tennessen as Chief Human Resources Officer

Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher

The Joint Corp. (NasdaqCM:JYNT)acquired Six franchised clinics in Northern California.

Insufficient new directors

Consensus forecasts updated

Price target decreased to US$28.08

Third quarter 2022 earnings released: EPS: US$0.034 (vs US$0.14 in 3Q 2021)

Price target decreased to US$30.08

The Joint Corp. Provides Earnings Guidance for the Fiscal Year 2022

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

The Joint Corp. to Report Q3, 2022 Results on Nov 03, 2022

The Joint Corp. Can Relieve You From High Inflation Pain

The Joint Corp. Reaffirms Revenue Guidance for 2022

Second quarter 2022 earnings released: EPS: US$0.024 (vs US$0.19 in 2Q 2021)

The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape

Investor sentiment improved over the past week

The Joint Corp. to Report Q2, 2022 Results on Aug 04, 2022

These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

The Joint Corp.(NasdaqCM:JYNT) dropped from Russell 2000 Growth-Defensive Index

Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?

Price target decreased to US$32.80

Insufficient new directors

The Joint Corp. provides Revenue Guidance for the Year 2022

The Joint Corp., Annual General Meeting, May 26, 2022

The Joint Corp. to Report Q1, 2022 Results on May 05, 2022

The Joint Corp. announced delayed annual 10-K filing

Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Consensus EPS estimates fall by 31%

Full year 2021 earnings: EPS misses analyst expectations

The Joint Corp. Provides Earnings Guidance for the Full Year of 2022

Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?

Investor sentiment deteriorated over the past week

Price target decreased to US$115

The Joint Corp. to Report Q4, 2021 Results on Feb 24, 2022

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?